Does TOCILIZUMAB Cause Upper respiratory tract infection? 1,455 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,455 reports of Upper respiratory tract infection have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 1.5% of all adverse event reports for TOCILIZUMAB.
1,455
Reports of Upper respiratory tract infection with TOCILIZUMAB
1.5%
of all TOCILIZUMAB reports
439
Deaths
372
Hospitalizations
How Dangerous Is Upper respiratory tract infection From TOCILIZUMAB?
Of the 1,455 reports, 439 (30.2%) resulted in death, 372 (25.6%) required hospitalization, and 190 (13.1%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for TOCILIZUMAB.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
LENALIDOMIDE (1,334)
Which TOCILIZUMAB Alternatives Have Lower Upper respiratory tract infection Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE